Monday, October 14, 2019
Sunday, October 13, 2019
Government Acts For Our Own Good....
When Individual Rights Are Eliminated, You Become Merely A Statistic.
Hunter Biden Leaves China Board as Trump Attacks Hit Home
Hunter Biden is walking away from the board of a Chinese-backed private equity company as part of a public pledge to disavow all foreign work if his father, former U.S. Vice President Joe Biden, gains the presidency in 2020.
Hunter Biden, Joe Biden’s second son, made his move after a month of pushing by U.S. President Donald Trump who has publicly highlighted the perceived – and real – conflicts of interest represented by Biden’s work in Asia.
A statement released on his behalf by his legal counsel George Mesires said his relationship with the management company of a private equity fund that’s backed by Chinese state-owned entities will end within weeks.
The 49-year-old doesn’t state whether he will be divesting from BHR (Shanghai) Equity Investment Fund Management Company in which he owns a stake. The company was set up in 2013 to invest Chinese capital outside of China.
Instead the young Biden pledged he wouldn’t work for any foreign-owned companies or serve on their boards during a potential Biden administration.
“Hunter always understood that his father would be guided, entirely and unequivocally, by established U.S. policy, regardless of its effects on Hunter’s professional interests,” the statement said. “He never anticipated the barrage of false charges against both him and his father by the President of the United States.”
Just two days ago Trump again highlighted the problem of Hunter Biden seeking work overseas during a political rally in Louisiana, as Breitbart News reported.
“He doesn’t know what a gasoline tank looks like,” Trump said, explaining Biden’s son knew nothing about energy despite earning up to $83,000 a month for sitting on a board of a corrupt energy company in Ukraine.
Trump then ripped Hunter for leaving China with $1.5 billion in investments from the bank of China despite knowing “nothing” and mocked the news broadcasts for repeatedly saying that Trump’s claims of corruption were “totally unsubstantiated” … at Biden’s request.
“It’s not unsubstantiated, he took a fortune out of Ukraine, knew nothing, took a fortune out of...
Everyday Things You Need An ID For...
The Only Valid Reason To Oppose Voter ID Is.....
Drug Prices Index Falls Fastest Since 1960s Thanks to Trump, His Economic Advisers Say
The consumer price index for prescription drugs has fallen 2.3 percent from its peak in June 2018 through September 2019, according to an analysis of data by the Bureau of Labor Statistics (BLS) by President Donald Trump’s Council of Economic Advisers (CEA). This price drop has been the fastest since the 1960s, aided by the quicker approvals of new and generic drugs by the Trump administration, according to the CEA.
Great news for American patients! Prescription drug prices FELL again last month and are now 2.3% below their peak. Increased generic drug approvals under @realDonaldTrump continue driving price reductions. Read our recent report on falling prices: whitehouse.gov/wp-content/upl…
2,204 people are talking about this
Faster Approvals
Average annual new drug approvals increased by nearly 72 percent in 2017 and 2018, compared to the period 2008–2016, the CEA said in an Oct. 10 paper (pdf). Average annual generic drug approvals, meanwhile, increased by almost 70 percent.
“The rate of drug approvals increased in 2017 and 2018, due in part to policies of the Trump Administration to expedite the drug approval process,” the paper stated.
If the 2017-2018 rate of drug approvals continues, it will save consumers between about $79 billion and $109 billion by 2027, the CEA estimated, when compared to an estimate using the 2008–2016 approval rate.
The estimated benefits were even higher when CEA counted in the value of having more new, presumably better drugs in the market.
Measuring Drug Prices
Gauging drug price movements can be complicated. The CEA paper criticized some media for using measurements that “can be misleading.”
Several media reported this year that prescription drug prices have been...
Gauging drug price movements can be complicated. The CEA paper criticized some media for using measurements that “can be misleading.”
Several media reported this year that prescription drug prices have been...
Subscribe to:
Comments (Atom)